A New Device for the Diagnosis and Investigation of Patients with Peripheral Arterial Occlusive Disease

Boissier, C.; Benichou, Annie Claude; Gamand, S; Perrot, Georges; Peyrieux, J C

doi:10.2165/00115677-199700021-00012

Cited by 6 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Ambulatory‐measured walking capacity was performed using either Global Positioning System (GPS) receivers (Le Faucheur et al., , ; Tew et al., ; Gernigon et al., ; Nordanstig et al., , ) or the Peripheral Arterial Disease Holter Control device (Boissier et al., ; Coughlin et al., , ). Although the latter allows clinicians to perform ambulatory measures, it was used only under laboratory conditions, most likely because the device is too cumbersome for the patients (http://onlinelibrary.wiley.com/doi/10.1111/sms.12512/suppinfo).…”

Section: Resultsmentioning

confidence: 99%

Clinical Interest of Ambulatory Assessment of Physical Activity and Walking Capacity in Peripheral Artery Disease

Müllenheim

Chaudru

Prioux

et al. 2015

Scandinavian Med Sci Sports

View full text Add to dashboard Cite

The purpose of the present review was to provide, for the first time, a comprehensive analysis and synthesis of the available studies that highlighted the clinical interest of the ambulatory assessment of either physical activity (PA) or walking capacity in patients with lower extremity peripheral artery disease (PAD). We identified 96 related articles published up to March 2015 through a computer-assisted search of the MEDLINE, EMBASE, and Web of Science databases. Ambulatory-measured PA or related energy expenditure (EE) in PAD patients was performed in 87 of the 96 included studies. The main clinical interests of these measurements were (a) the assessment of PA/EE pattern; (b) the characterization of walking pattern; and (c) the control of training load during home-based walking programs. Ambulatory-measured walking capacity was performed in the remaining studies, using either Global Positioning System receivers or the Peripheral Arterial Disease Holter Control device. Highlighted clinical interests were (a) the assessment of community-based walking capacity; (b) the use of new outcomes to characterize walking capacity, besides the conventional absolute claudication distance; and (c) the association with the patient's self-perception of walking capacity. This review also provides for the clinicians step-by-step recommendations to specifically assess PA or walking capacity in PAD patients.

show abstract

Section: Resultsmentioning

confidence: 99%

Clinical Interest of Ambulatory Assessment of Physical Activity and Walking Capacity in Peripheral Artery Disease

Müllenheim

Chaudru

Prioux

et al. 2015

Scandinavian Med Sci Sports

View full text Add to dashboard Cite

show abstract

“…2). 8 The speed at which the ankle pressure recovers to its initial preexercise value varies according to the functional state of the collateral circulation. After the patient has rested, standing, for one minute the pain subsides but the ankle pressure may still remain at a lower value than that prior to the initial walking period.…”

Section: Principle Of the Double Physiological Walking Tests With The Padhoc Systemmentioning

confidence: 99%

“…5e7 The PADHOC (Peripheral Arterial Disease Holter Control Device) device and the associated Double Physiological Walking Test (DPWT) is a novel way of determining a claudicants walking distance. 3,8 The aim of this study was to determine whether the PADHOC was a superior measure of functional incapacity in claudicants, when compared to a CLTT.…”

Section: Introductionmentioning

confidence: 99%